Sunday 30 September 2012

Novartis's smokers' cough treatment gets European nod


An employee smokes a cigarette beside the logo of Swiss drugmaker Novartis AG in front of a plant in Basel ZURICH (Reuters) - Swiss drugmaker Novartis said on Monday the European Commission had approved its Seebri Breezhaler as a once-daily treatment for adult patients with chronic obstructive pulmonary disease, more commonly known as smoker's cough, in the European Union. Trials showed that the treatment significantly improved lung function over the first four hours after morning dosing when compared to placebo, and that this benefit was sustained for 24 hours over a 52-week period, Novartis said. ...








via Health News Headlines - Yahoo! News Read More Here..





Lake forest health and fitness http://healthandfitness1blog.blogspot.com/2012/10/novartis-smokers-cough-treatment-gets_1.html

No comments:

Post a Comment